000 01016 a2200313 4500
005 20250512142156.0
264 0 _c19720419
008 197204s 0 0 eng d
022 _a0007-1447
024 7 _a10.1136/bmj.1.5794.220
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrooks, R V
245 0 0 _aHyperaldosteronism from adrenal carcinoma.
_h[electronic resource]
260 _bBritish medical journal
_cJan 1972
300 _a220-1 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenal Gland Neoplasms
_xcomplications
650 0 4 _aAdult
650 0 4 _aCarcinoma
_xcomplications
650 0 4 _aHumans
650 0 4 _aHyperaldosteronism
_xdrug therapy
650 0 4 _aMale
650 0 4 _aSpironolactone
_xtherapeutic use
700 1 _aFelix-Davies, D
700 1 _aLee, M R
700 1 _aRobertson, P W
773 0 _tBritish medical journal
_gvol. 1
_gno. 5794
_gp. 220-1
856 4 0 _uhttps://doi.org/10.1136/bmj.1.5794.220
_zAvailable from publisher's website
999 _c5061187
_d5061187